The Bipartisan Commission on Biodefense met at the University of Michigan on April 10, bringing together former federal leaders and experts to talk through pandemic readiness, biotech security, and medical supply chains. The discussion also raised concerns about recent cuts to research funding and global health efforts. The full article breaks down what’s at stake and why it matters now.
